Antidiabetic and Antihyperlipidemic Effects of Myristica fragrans. in Animal Models

References

• Arulmozhi DK, Portha B (2006): GLP-1 based therapy for type 2 diabetes. Eur J Pharm Sci 28: 96–108.
   PubMed Web of Science ®Google Scholar
• Capasso R, Pinto L, Vuotto ML, Di Carlo G (2000): Preventive effect of eugenol on PAF and ethanol induced gastric mucosal damage. Fitoterapia 71: S131–S137.
   Google Scholar
• Chakrabarti R, Mishra P, Vikramadithyan RK, Premkumar M, Hiriyan J, Datla SR, Darmala RKB, Suresh J, Rajagopalan R (2004): Antidiabetic and hypolipidemic potential of DRF 2519-a dual activator of PPAR-α and PPAR-γ. Eur J Pharmacol 491: 195–206.
   PubMed Web of Science ®Google Scholar
• Chiu HC, Kovacs A, Blanton DA, Hsu FF, Garcia R, Herrero P, Saffitz JE, Schaffer JE (2001): A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 107: 813–522.
   PubMed Web of Science ®Google Scholar
• Chung JY, Choo JH, Lee MH, Hwang JK (2006): Anticariogenic activity of macelignan isolated from Myristica fragrans. (nutmeg) against Streptococcus mutans.. Phytomedicine 13: 261–266.
   PubMed Web of Science ®Google Scholar
• Dwyer DS, Donohoe D (2003): Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake. Pharmacol Biochem Behav 75: 255–260.
   PubMed Web of Science ®Google Scholar
• Forrest JL, Heacock RA (1972): Identification of the major components of the essential oil of mace. J Chromatogr A 69: 115–121.
   Google Scholar
• Grover GK, Yadav S, Vats V (2002): Medicinal plants in India with antidiabetic potential. J Ethnopharmacol 81: 81–100.
   PubMed Web of Science ®Google Scholar
• Isogai A, Suzuki A, Tamura S (1973): Structure of dimeric phenoxyprapanoids from Myristica fragrans.. Agric Biol Chem 37: 193–194.
   Web of Science ®Google Scholar
• Jan M, Faqir F, Jamida, Mughal MA (2005): Comparison of effects of extract of Myristica fragrans. and verapamil on the volume and acidity of carbachol induced gastric secretion in fasting rabbits. J Ayub Med Coll Abbottabad 17: 69–71.
   PubMedGoogle Scholar
• Janssen J, Laekeman GM, Peiters LA, Totte J, Herman AG, Vlietinck AJ (1990): Nutmeg oil: Identification and quantification of its most active constituents as inhibitors of platelet aggregation. J Ethnopharmacol 29: 179–188.
   PubMedGoogle Scholar
• Li X, Catalina F, Grundy SM, Patel S (1996): Method to measure the apolipoprotein B-48 and B-100 secretion rates in an individual mouse: Evidence for a very rapid turnover of VLDL and preferential removal of B-48 relative to B-100 containing lipoproteins. J Lipid Res 37: 210–220.
   PubMedGoogle Scholar
• Luo J, Cheung J, Yevich EM, Clark JP, Tsai J, Lapresca P, Ubillas RP, Fort DM, Carlson TJ, Hector RF, King SR, Mendez CD, Jolad SD, Reaven GM (1999): Novel terpenoid-type quinones isolated from Pycnanthus angolensis. of potential utility in the treatment of type 2 diabetes. J Pharmacol Exp Ther 288: 529–534.
   PubMed Web of Science ®Google Scholar
• Morita T, Jinno K, Kawagishi H, Arimoto Y, Suganuma H, Inakuma T, Sugiyama K (2003): Hepatoprotective effect of myristicin from nutmeg (Myristica fragrans.) on lipopolysaccharide/d-galactosaminde induced liver injury. J Agri Food Chem 51: 1560–1565.
   PubMed Web of Science ®Google Scholar
• Ozaki Y, Soedigdo S, Wattimena YR, Suganda AG (1989): Antiinflammatory effect of mace, aril of Myristica fragrans. Houtt., and its active principles. Jpn J Pharmacol 49: 155–163.
   PubMedGoogle Scholar
• Park S, Lee DK, Yang CH (1998): Inhibition of foc-jun-DNA complex formation by dihydroguaiaretic acid and in vitro. cytotoxic effects on cancer cells. Cancer Lett 127: 23–28.
   PubMed Web of Science ®Google Scholar
• Parle MN, Dhingra D, Kulkarni SK (2004): Improvement of mouse memory by Myristica fragrans. seeds. J Med Food 7: 157–161.
   PubMed Web of Science ®Google Scholar
• Petit D, Bonnefis MT, Rey C (1988): Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats. Atherosclerosis 74: 215–225.
   PubMed Web of Science ®Google Scholar
• Ram A, Luria P, Gupta R, Sharma VN (1996): Hypolipidaemic effect of Myristica fragrans. fruit extract in rabbits. J Ethnopharmacol 55: 49–53.
   PubMed Web of Science ®Google Scholar
• Sharma A, Mathur R, Dixit VP (1995): Prevention of hypercholesterolemia and atherosclerosis in rabbits after supplementation of Myristica fragrans. seed extract. Indian J Physiol Pharmacol 4: 407–410.
   Google Scholar
• Sonavane G, Sarveiya V, Kasture V, Kasture S (2001): Behavioral actions of Myristica fragrans. seeds. Indian J Pharmacol 33: 417–424.
   Google Scholar
• Sonavane GS, Sarveiya VP, Kasture VS, Kasture SB (2002): Anxiogenic activity of Myristica fragrans. seeds. Pharmacol Biochem Behav 71: 239–244.
   PubMed Web of Science ®Google Scholar
• Xie H, Lautt WW (1995): Induction of insulin resistance by cholinergic blockade with atropine in the cat. J Autn Pharmacol 15: 361–369.
   PubMedGoogle Scholar
• Zang BB, Moller DE (2000): New approaches in the treatment of type 2 diabetes. Curr Opin Chem Biol 4: 461–467.
   PubMedGoogle Scholar
• Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unfger RH (2000): Lipotoxic heart disease in obese rats: Implications for human obesity. Proc Natl Acad Sci, USA 97: 1784–1789.
   PubMed Web of Science ®Google Scholar